• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    2.34 Down 0.07(2.90%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:2.41
    Open:2.35
    Bid:0.70 x 400
    Ask:N/A
    1y Target Est:2.00
    Beta:0.89
    Next Earnings Date:N/A
    Day's Range:2.33 - 2.41
    52wk Range:0.39 - 3.68
    Volume:27,815
    Avg Vol (3m):99,805
    Market Cap:29.56M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECTE

    Comparison

    Symbol% ChgMkt Cap
    ECTEDown 2.90%29.56M
    ABTDown 0.50%71.33B
    DXCMDown 1.97%4.71B
    MDTDown 1.55%76.33B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,764.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.19
    Quarterly EPS Est (Dec-14) :-0.32
    Mean Recommendation*:5.0
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback